These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11079901)

  • 1. Liver guide for monitoring of chronic hepatitis C.
    Hedin K; Babic A; Frydén A
    Proc AMIA Symp; 2000; ():340-3. PubMed ID: 11079901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
    Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
    J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hyaluronic acid, its degrading enzymes, degradation products, and ferritin in the assessment of fibrosis stage in Egyptian patients with chronic hepatitis C.
    El-mezayen HA; Toson el-SA; Shiha GE
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):69-76. PubMed ID: 23011038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of non-invasive serum markers for predicting liver fibrosis in Egyptian patients with chronic HCV infection.
    El Guesiry D; Moez P; Hossam N; Kassem M
    Egypt J Immunol; 2011; 18(2):1-12. PubMed ID: 23082465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C.
    Luo JC; Hwang SJ; Chang FY; Chu CW; Lai CR; Wang YJ; Lee PC; Tsay SH; Lee SD
    Hepatogastroenterology; 2002; 49(44):478-81. PubMed ID: 11995477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis.
    Cheong JY; Um SH; Seo YS; Shin SS; Park RW; Kim DJ; Hwang SG; Lee YJ; Cho M; Yang JM; Kim YB; Park YN; Cho SW
    Hepatogastroenterology; 2012; 59(120):2592-7. PubMed ID: 23178625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
    Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
    J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
    Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
    Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.
    Fernandes FF; Ferraz ML; Andrade LE; Dellavance A; Terra C; Pereira G; Pereira JL; Campos F; Figueiredo F; Perez RM
    J Clin Gastroenterol; 2015 Mar; 49(3):235-41. PubMed ID: 24714186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possibility of Using ELF Score as Index for Hepatic Fibrosis Evaluation].
    Asano H
    Rinsho Byori; 2015 Jan; 63(1):78-83. PubMed ID: 26524882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive clinical assessment improves the accuracy of predicting cirrhosis in chronic hepatitis C.
    Gordon A; Bailey MJ; Gibson PR; Roberts SK
    J Gastroenterol Hepatol; 2005 Jun; 20(6):825-32. PubMed ID: 15946128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis.
    Rossi E; Adams LA; Ching HL; Bulsara M; MacQuillan GC; Jeffrey GP
    Clin Chem Lab Med; 2013 May; 51(5):1107-14. PubMed ID: 23152415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.
    Lebensztejn DM; Wierzbicka A; Socha P; Pronicki M; Skiba E; Werpachowska I; Kaczmarski M
    Acta Biochim Pol; 2011; 58(4):563-6. PubMed ID: 22140659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation in patients with chronic hepatitis C.
    Fusegawa H; Shiraishi K; Ogasawara F; Shimizu M; Haruki Y; Miyachi H; Matsuzaki S; Ando Y
    Tokai J Exp Clin Med; 2002 Dec; 27(4):101-6. PubMed ID: 12713014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct and indirect evidence for the reversibility of cirrhosis.
    Serpaggi J; Carnot F; Nalpas B; Canioni D; Guéchot J; Lebray P; Vallet-Pichard A; Fontaine H; Bedossa P; Pol S
    Hum Pathol; 2006 Dec; 37(12):1519-26. PubMed ID: 16997354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
    Kozłowska J; Łoch T; Jabłońska J; Cianciara J
    Przegl Epidemiol; 2001; 55(4):451-8. PubMed ID: 11921731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.